ankylosing%20spondylitis
ANKYLOSING SPONDYLITIS
Spondyloarthritis refers to a group of inflammatory diseases characterized by spinal & joint oligoarthritis, enthesitis, and sometimes mucocutaneous, ocular and/or cardiac manifestations.
Ankylosing spondylitis is a prototype of spondyloarthritis, particularly of the axial form.
Diagnosis of ankylosing spondylitis is definite if any of the radiological criterion (grade≥2 bilateral sacroiliitis or grade ≥3 unilateral sacroiliitis) is associated with at least one of the clinical criterion (low back pain & stiffness for >3 months that improves with exercise but not relieved by rest, limitation of motion of the lumbar spine in the sagittal and frontal planes, limitation of chest expansion relative to normal values correlated for age and gender.

Introduction

  • Spondyloarthritis (SPA) refers to a group of inflammatory diseases characterized by spinal and joint oligoarthritis, enthesitis, and sometimes, mucocutaneous, ocular, and/or cardiac manifestations 

Definition

  • Ankylosing spondylitis (AS) is a prototype of spondyloarthritis (SPA), particularly of the axial form of spondyloarthritis (SPA)

Signs and Symptoms

Main Clinical Manifestations

  • Inflammatory back pain (IBP) or chronic back pain persisting for >3 months, confirmed by 4 of the following:
    • Onset before 40 years of age
    • Insidious onset
    • Improves with exercise
    • Nocturnal pain with improvement upon getting up
    • Associated with morning stiffness not improved by rest
  • Inflammation of the attachments of ligaments and tendons to bones (enthesitis)
  • Peripheral arthritis
  • Ankylosis
  • Dactylitis
  • Anterior uveitis

Clinical Manifestations of Ankylosing Spondylitis

  • Inflammatory back pain (IBP)
  • Chest pain/costochondritis
  • Alternate buttock pain
  • Acute anterior uveitis
  • Synovitis predominantly of lower limbs, asymmetric
  • Enthesitis (eg heel, plantar)
  • Radiographic sacroiliitis
  • Positive family history of ankylosing spondylitis (AS), chronic inflammatory bowel disease (IBD) or psoriasis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 17 Oct 2017
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Kavitha G. Shekar, 14 Jun 2016
The incidence of type 1 diabetes mellitus (T1D) was found to be higher in juvenile idiopathic arthritis patients (JIA) compared with the general population, said German researchers at the European League Against Rheumatism Annual Congress (EULAR 2016) held in London, UK.
Elaine Tan, 29 Jun 2017

Tofacitinib, a first-in-class Janus kinase (JAK) inhibitor, shows promise as an oral treatment with quick onset of action and sustained efficacy in patients with psoriatic arthritis (PsA) who do not respond adequately to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). 

Dr. Priscilla Wong, Dr. Lydia Tam, Prof. LS Tam, 10 Nov 2017
This case report highlights that psoriatic arthritis is a heterogenous disease affecting multiple disease domains, and effective treatment requires thorough assessment of each of these different domains.